Helsinn Therapeutics
AKYNZEO
Manufacturer:
Helsinn Therapeutics
Name:
AKYNZEO
HCPCS Code Descriptor:
Netupitant 300 mg and palonosetron 0.5 mg, oral
Category:
J Code
HCPCS:
J8655
NDC(s):
69639-0101-01
Primary Type:
Oncology-Anti-Emetic
Generic Status:
Single-Source
Route of Administration:
Oral
About:
AKYNZEO is an Oncology-Anti-Emetic drug manufactured by Helsinn Therapeutics and administered via the Oral route of administration. The J Code: J8655 is aligned to the drug AKYNZEO.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/16
HCPCS Effective Date:
1/1/19
HCPCS Short Description:
Oral netupitant, palonosetro
Billing and Coding Guide:
https://helsinnreimbursement.com/pdfs/V-AKYN-US-0544-AKYNZEO-Capsules-Billing-Coding-Guide.pdf
Patient Assistance:
https://helsinnreimbursement.com/
https://helsinnreimbursement.com/